A press release on the Unaudited Financial Results for the quarter and six months ended 30th September, 2026 is enclosed herewith.

Page 1 of 15 KANSAI NEROLAC PAINT 4th November, 2026 1. Corporate Relationship Department 2. Manager – Listing BSE Limited National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai - 400001. Mumbai - 400 051. Sub.: Outcome of the Board Meeting of Kansai Nerolac Paints Limited held on 4th November, 2026 Ref.: 1. Regulation 30 (read with Schedule III - Part A), Regulation 33 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 2. BSE Scrip Code- 500165, NSE Symbol- KANSAINER Dear Sirs, This is to inform you that the Board of Directors of Kansai Nerolac Paints Limited has, in its meeting held today i.e. on Wednesday, 4th November, 2026, inter alia considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and six months ended 30th September, 2026 (“Unaudited Financial Results”). The Board Meeting commenced at 4.00 p.m. and concluded at 6.45 p.m. Further, pursuant to the applicable provisions of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Regulations”), please find enclosed herewith: (i) the Unaudited Financial Results for the quarter and six months ended 30th September, 2026; and (ii) Limited Review Report dated 4th November, 2026, issued by the Statutory Auditors of the Company with respect to the Unaudited Financial Results and taken on record by the Board of Directors of the Company. A press release on the Unaudited Financial Results is also enclosed herewith. Necessary arrangements have been made for publishing the Unaudited Financial Results in the newspapers, in the prescribed formats, in terms of Regulation 47 of SEBI Listing Regulations. For KANSAI NEROLAC PAINTS LIMITED G. T. GOVINDARAJAN COMPANY SECRETARY Encl.: As above. KANSAI NEROLAC PAINTS LIMITED Registered Office: 28th Floor. A-wing. Marathon Futurex. N. M. Joshi Marg. Lower Parel. Mumbai -400 013. India T: •9122 4060 2500/2501 I www.nerolac.com CIN L24202MH1920PLC000825 Page 2 of 15 SRB C& COLLP 1st Floor, Block B-7, North Side Chartered Accountants Nirlon Knowledge Park, Near Hub Mall Off Western Express Highway Goregaon (E), Mumbai -400 063, India Tel : +91 22 6819 8000 Independent Auditor's Review Report on the Quarterly and Vear to Date Unaudited Standalone Financial Results of the Company Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended Review Report to The Board of Directors Kansai Nerolac Paints Limited 1. We have reviewed the accompanying statement of unaudited standalone financial results of Kansai Nerolac Paints Limited (the "Company") for the quarter ended September 30, 2026 and year to date from April 01, 2026 to September 30, 2026 (the "Statement") attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the "Listing Regulations"). 2. The Company's Management is responsible for the preparation of the Statement in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, (Ind AS 34) "Interim Financial Reporting" prescribed under Section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. The Statement has been approved by the Company's Board of Directors. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standards ('Ind AS') specified under Section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. For S R B C & CO LLP Chartered Accountants ICAI Firm registration number: 324982E/E300003 per Shyamsundar Pachisia Partner Membership No: 049237 UDIN:160!.t92.3fX &JlE 82 Place: Mumbai Date: November 04, 2026 SR BC & CO LLP, a Limited Llllbility Pllrlnenhip with LLP Identity No. AAB·4318 Regd. Office: 22. Camac Street. Block '8'. 3rd noor. Kolkara-700 016 Page 3 of 15 KANSAI NEROLAC PAINTS LIMITED Registered Office: 28th Floor. A• Wing, Marathon Futurex, N. M. Joshi Marg, Lower Parel, Mumbai. 400 013 Tel: +91-22-40602500; e-mail: inveslor@nerolac.com Website: www.nerolac.com CIN: l24202MH1920PLC000825 STATEMENT OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER AND SIX MONTHS ENDED 30 SEPTEMBER 2026 ,n rores For the quarter ended For the six months ended For the year ended Sr. No. Particulars 30.09.2026 30.06.2026 30.09.2025 30.09.2026 30.09.2025 31.03.2026 (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited) Refer Note 4 Refer Note4 Refer Note 4 Refer Note 4 Refer Note4 Refer Note 4 1 Income Revenue from Operations 2268.77 2332.83 1907.46 4601.60 4030.69 7887.55 Other Income 35.57 55.18 28.65 90.75 81.57 150.18 Total Income 2304.34 2388.01 1936.11 4692.35 4112.26 8037.73 2 Expenses a. Cost of Materials Consumed 1586.54 1490.62 1104.71 3077.16 2258.33 4492.41 b. Purchase of Stock-in-Trade 132.10 144.48 124.98 276.58 261.40 507.21 C. Changes in Inventories of Finished Goods, Work-in-Progress and Stock-in-Trade (127.89) (115.26) 9.91 (243.15) 78.53 102.73 d. Employee Benefits Expense 134.62 130.69 129.73 265.31 255.16 510.09 e. Finance Costs 4.88 4.96 4.44 9.84 8.82 19.72 f. Depreciation and Amortisation Expense 61.94 61.67 52.95 123.61 104.56 222.94 g. Other Expenses 320.17 352.42 325.38 672.59 654.64 1288.92 Total Expenses 2112.36 2069.58 1752.10 4181.94 3621.44 7144.02 3 Profit before exceptional items and tax 191.98 318.43 184.01 510.41 490.82 893.71 4 Exceptional Items (63.15) 5 Profit before tax 191.98 318.43 184.01 510.41 490.82 830.56 6 Tax Expense a. Current Tax 44.38 82.87 45.53 127.25 123.89 214.73 b. Adjustment of tax relating to earlier periods 4.02 C. Deferred Tax (1.04) 0.54 1.92 (0.50) 2.79 (0.39) Total Tax Expense 43.34 83.41 47.45 126.75 126.68 218.36 7 Profit for the Period 148.64 235.02 136.56 383.66 364.14 612.20 8 Other Comprehensive Income (i) Items that will not be reclassified to Statement of Profit and Loss 0.05 0.06 (0.87) 0.11 (1.75) 9.48 (ii) Income tax on item that will not be reclassified to Statement of Profit and Loss (0.02) (0.01) 0.22 (0.03) 0.44 (2.27) 9 Other Comprehensive Income (net of tax) 0.03 0.05 (0.65) 0.08 (1.31) 7.21 10 Total Comprehensive Incom [Showing first 8,000 characters — download PDF for full document]